Insider · CIK 0001604646

Cole Hugh M

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001604646

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,333 sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.7K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26.6K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2026-01-23	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2025-06-11	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.6K sh	—	—	26,550
2024-06-05	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2023-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,100
2023-01-10	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−9,182 sh	$1.12	−$10.3K	110,082
2023-01-09	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−7,452 sh	$1.10	−$8,197.2	119,264
2022-08-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+40K sh	—	—	40,000
2022-08-01	Jounce Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+20K sh	—	—	126,716
2022-06-09	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2022-06-09	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2022-02-01	Jounce Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+42.5K sh	—	—	106,716
2022-02-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+85K sh	—	—	85,000
2022-02-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+85K sh	—	—	85,000
2022-01-10	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−6,205 sh	$6.65	−$41.3K	64,216
2022-01-07	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,468 sh	$7.30	−$25.3K	70,421
2021-06-02	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2021-02-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+53.4K sh	$11.89	+$635K	53,400
2021-02-01	Jounce Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+26.7K sh	—	—	73,889
2021-01-22	Jounce Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	39,500
2021-01-22	Jounce Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$6.55	+$32.8K	65,189
2021-01-22	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−18K sh	$11.95	−$215K	47,189
2021-01-22	Jounce Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	55,000
2021-01-22	Jounce Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$4.40	+$22K	60,189
2021-01-08	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,340 sh	$7.00	−$23.4K	55,189
2021-01-07	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,879 sh	$6.76	−$19.5K	58,529
2020-08-18	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−744 sh	$4.71	−$3,504.24	61,408
2020-08-17	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−454 sh	$4.86	−$2,206.44	62,152
2020-08-14	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−984 sh	$4.64	−$4,565.76	62,606
2020-06-11	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-02-03	Jounce Therapeutics, Inc.Common StockA Award	Chief Operating Officer	AAward	+60K sh	—	—	60,000
2020-02-03	Jounce Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+30K sh	—	—	63,590
2020-01-07	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,624 sh	$7.78	−$20.4K	33,590
2019-08-16	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,018 sh	$3.92	−$3,990.56	36,214
2019-08-15	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−648 sh	$4.00	−$2,592	37,232
2019-08-14	Jounce Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−670 sh	$4.10	−$2,747	37,880
2019-07-26	ATXSAstria Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-02-01	Jounce Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+22.3K sh	—	—	38,550
2019-02-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+44.5K sh	—	—	44,500
2018-08-13	Jounce Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+14.4K sh	—	—	16,300
2018-06-15	Jounce Therapeutics, Inc.P Purchase	Chief Operating Officer	PPurchase	+1,900 sh	$7.84	+$14.9K	1,900
2018-02-01	Jounce Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+70.5K sh	—	—	70,500
2017-02-16	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−9,788 sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−78K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−64.7K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCD Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−42.8K sh	—	—	0
2017-02-16	ARIAD PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)D Disposition to Issuer	SVP, Chief Business Officer	DDisposition to Issuer	−100K sh	—	—	0

Recent filings

Accepted (ET)
Jan 234
Cole Hugh M0000905148-26-000316
SEC(opens sec.gov)
Jun 124
Cole Hugh M0001104659-25-059039
SEC(opens sec.gov)
Jun 64
Cole Hugh M0001104659-24-069068
SEC(opens sec.gov)
Jun 64
Cole Hugh M0001104659-23-068339
SEC(opens sec.gov)
Jan 114
Cole Hugh M0001640455-23-000008
SEC(opens sec.gov)
Aug 34
Cole Hugh M0001640455-22-000084
SEC(opens sec.gov)
Jun 214/A
Cole Hugh M0001104659-22-072750
SEC(opens sec.gov)
Jun 94
Cole Hugh M0001104659-22-069755
SEC(opens sec.gov)
Mar 174/A
Cole Hugh M0001640455-22-000035
SEC(opens sec.gov)
Feb 34
Cole Hugh M0001640455-22-000019
SEC(opens sec.gov)
Jan 114
Cole Hugh M0001640455-22-000008
SEC(opens sec.gov)
Jun 24
Cole Hugh M0001104659-21-075901
SEC(opens sec.gov)

Companies

Address

C/O ASTRIA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 10TH FLOOR

BOSTON, MA, 02210